Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001628280-24-049149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-25 | 2024-11-21+ | AMRX | Autor Deborah M. | Dir | S - Sale | $8.35 | -40.0K | 86.6K | -32% | -$334.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-22 | S | D | 33,229 | $8.34 | 53,402 | D | — | — | (F2) The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 per share to $8.41 per share, inclusive. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Class A Common Stock | 2024-11-21 | S | D | 6,771 | $8.41 | 86,631 | D | — | — | (F1) The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.38 to $8.47 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote. |